Rivastigmine Transdermal System Articles
Actavis confirms generic Exelon Patch patent challenge; InnoPharma debuts generic Vistide in USA
9 March 2013
FDA backs higher dose of Novartis Exelon Patch for Alzheimer's
4 September 2012
Novartis posts 50% 4th-qtr 2009 profits rise and promotes drugs chief Jimenez to CEO; other top changes
26 January 2010
Novartis' 1st-qtr 2009 results boosted by new products
24 April 2009
Novartis' Exelon not widely used by PCPs
3 December 2007
Novartis' Exelon patch launched in the UK
29 October 2007
Tokyo stocks to October 8, 2007
15 October 2007
Exelon gets EC OK for Alzheimer's disease
1 October 2007
CHMP recommends approval Exelon patch
30 July 2007
Japan stock market week to July 16, 2007
23 July 2007
Stock Commentary - Europe - week to July 9, 2007
16 July 2007
Novartis' Exelon patch "better than tablet"
31 July 2006
Showing 1-19 of 19 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
